Take a look at this month's top headlines.
Antitransgender discourse reinforces attacks on reproductive rights.
Consider the needs of marginalized patients to promote equity
Nearly half (45%) of all pregnancies in the United States from 2015 to 2019 were unintended.
Despite a painful history, equitable care is imperative
In a recent study, prenatal cannabis exposure was associated with greater risk of behavioral problems and mental health disorders in children.
In a recent study, offspring delivered through cesarean section were more likely to develop Crohn’s disease than those vaginally delivered.
An analysis of data from more than 100,000 individuals living in Europe is providing insight into the risk of cardiovascular disease associated with consumption of artificial sweeteners.
In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.
The medication also performed comparably to vulvovaginal candidiasis (VVC) standard-of-care fluconazole for treating acute VVC infection.
Research in Menopause connects history of physical/sexual abuse, financial instability with worse menopausal symptoms and overall wellbeing at midlife.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More